Anthrax protective antigen forms oligomers during intoxication of mammalian cells - PubMed

Affiliations

• PMID: 8051159

Free article

Anthrax protective antigen forms oligomers during intoxication of mammalian cells

J C Milne et al. J Biol Chem. 1994.

Free article

Abstract

The protective antigen component (PA) of anthrax toxin binds to receptors on target cells and conveys the toxin's edema factor (EF) and lethal factor (LF) components into the cytoplasm. PA (83 kDa) is processed by a cellular protease, yielding a 63-kDa fragment (PA63), which binds EF and/or LF. When exposed to acidic pH, PA63 inserts into membranes and forms ion-conductive channels. By electron microscopy, a significant fraction of purified PA63 was found to be in the form of a multi-subunit ring-shaped oligomer (outer diameter, 10.4 nm). The rings are heptameric, as judged by inspection and by rotational power spectra. Purified PA63 showed a high M(r) band, apparently corresponding to the oligomer, on SDS-polyacrylamide gels, and oligomer of similar size was formed in cells in a time-dependent manner after addition of full-length PA. Inhibitors of internalization and endosome acidification blocked conversion of cell-associated PA to a high molecular weight species, and medium at pH 5.0 induced oligomer formation in the presence or absence of the inhibitors. These results correlate PA63 oligomerization with conditions required for translocation of EF and LF across lipid bilayers, implying that the PA63 oligomer may function in translocation.

Similar articles

• Effect of anthrax toxin's lethal factor on ion channels formed by the protective antigen.

  Zhao J, Milne JC, Collier RJ. Zhao J, et al. J Biol Chem. 1995 Aug 4;270(31):18626-30. doi: 10.1074/jbc.270.31.18626. J Biol Chem. 1995. PMID: 7543106

• [Molecular model of anthrax toxin translocation into target-cells].

  Noskov AN. Noskov AN. Bioorg Khim. 2014 Jul-Aug;40(4):399-404. doi: 10.1134/s1068162014040098. Bioorg Khim. 2014. PMID: 25898749 Review. Russian.

• The channel formed in planar lipid bilayers by the protective antigen component of anthrax toxin.

  Finkelstein A. Finkelstein A. Toxicology. 1994 Feb 28;87(1-3):29-41. doi: 10.1016/0300-483x(94)90153-8. Toxicology. 1994. PMID: 7512762 Review.

• A dominant negative mutant of Bacillus anthracis protective antigen inhibits anthrax toxin action in vivo.

  Singh Y, Khanna H, Chopra AP, Mehra V. Singh Y, et al. J Biol Chem. 2001 Jun 22;276(25):22090-4. doi: 10.1074/jbc.M010222200. Epub 2001 Mar 16. J Biol Chem. 2001. PMID: 11278644

• Oligomerization of anthrax toxin protective antigen and binding of lethal factor during endocytic uptake into mammalian cells.

  Singh Y, Klimpel KR, Goel S, Swain PK, Leppla SH. Singh Y, et al. Infect Immun. 1999 Apr;67(4):1853-9. doi: 10.1128/IAI.67.4.1853-1859.1999. Infect Immun. 1999. PMID: 10085027 Free PMC article.

Cited by

• The Disulfide Bond Cys255-Cys279 in the Immunoglobulin-Like Domain of Anthrax Toxin Receptor 2 Is Required for Membrane Insertion of Anthrax Protective Antigen Pore.

  Jacquez P, Avila G, Boone K, Altiyev A, Puschhof J, Sauter R, Arigi E, Ruiz B, Peng X, Almeida I, Sherman M, Xiao C, Sun J. Jacquez P, et al. PLoS One. 2015 Jun 24;10(6):e0130832. doi: 10.1371/journal.pone.0130832. eCollection 2015. PLoS One. 2015. PMID: 26107617 Free PMC article.

• X-ray and Cryo-electron Microscopy Structures of Monalysin Pore-forming Toxin Reveal Multimerization of the Pro-form.

  Leone P, Bebeacua C, Opota O, Kellenberger C, Klaholz B, Orlov I, Cambillau C, Lemaitre B, Roussel A. Leone P, et al. J Biol Chem. 2015 May 22;290(21):13191-201. doi: 10.1074/jbc.M115.646109. Epub 2015 Apr 5. J Biol Chem. 2015. PMID: 25847242 Free PMC article.

• Early Circulating Edema Factor in Inhalational Anthrax Infection: Does It Matter?

  Tessier E, Cheutin L, Garnier A, Vigne C, Tournier JN, Rougeaux C. Tessier E, et al. Microorganisms. 2024 Jan 31;12(2):308. doi: 10.3390/microorganisms12020308. Microorganisms. 2024. PMID: 38399712 Free PMC article.

• Antibodies against anthrax: mechanisms of action and clinical applications.

  Froude JW 2nd, Thullier P, Pelat T. Froude JW 2nd, et al. Toxins (Basel). 2011 Nov;3(11):1433-52. doi: 10.3390/toxins3111433. Epub 2011 Nov 16. Toxins (Basel). 2011. PMID: 22174979 Free PMC article. Review.

• Human monoclonal antibodies against anthrax lethal factor and protective antigen act independently to protect against Bacillus anthracis infection and enhance endogenous immunity to anthrax.

  Albrecht MT, Li H, Williamson ED, LeButt CS, Flick-Smith HC, Quinn CP, Westra H, Galloway D, Mateczun A, Goldman S, Groen H, Baillie LW. Albrecht MT, et al. Infect Immun. 2007 Nov;75(11):5425-33. doi: 10.1128/IAI.00261-07. Epub 2007 Jul 23. Infect Immun. 2007. PMID: 17646360 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Elsevier Science

• Other Literature Sources

  • The Lens - Patent Citations Database